Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity

References

• Orfila C, Rakotoarivony J, Manuel Y, Suc JM. Immunofluorescence characterization of light chains in human nephropathies. Virchows Arch A Pathol Anat Histopathol 1988; 412:591 - 4; http://dx.doi.org/10.1007/BF00844295; PMID: 3129870
   PubMedGoogle Scholar
• Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 2006; 24:1241 - 52; http://dx.doi.org/10.1038/nbt1252; PMID: 17033665
   PubMed Web of Science ®Google Scholar
• Schneider CK, Kalinke U. Toward biosimilar monoclonal antibodies. Nat Biotechnol 2008; 26:985 - 90; http://dx.doi.org/10.1038/nbt0908-985; PMID: 18779806
   PubMed Web of Science ®Google Scholar
• Reichert JM, Valge-Archer VE. Development trends for monoclonal antibody cancer therapeutics. Nat Rev Drug Discov 2007; 6:349 - 56; http://dx.doi.org/10.1038/nrd2241; PMID: 17431406
   PubMed Web of Science ®Google Scholar
• Nelson AL, Reichert JM. Development trends for therapeutic antibody fragments. Nat Biotechnol 2009; 27:331 - 7; http://dx.doi.org/10.1038/nbt0409-331; PMID: 19352366
   PubMed Web of Science ®Google Scholar
• Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 2009; 8:226 - 34; http://dx.doi.org/10.1038/nrd2804; PMID: 19247305
   PubMed Web of Science ®Google Scholar
• Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6:343 - 57; http://dx.doi.org/10.1038/nri1837; PMID: 16622479
   PubMed Web of Science ®Google Scholar
• Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 2010; 10:345 - 52; http://dx.doi.org/10.1038/nri2747; PMID: 20414207
   PubMed Web of Science ®Google Scholar
• Reichert JM. Marketed therapeutic antibodies compendium. MAbs 2012; 4:413 - 5; http://dx.doi.org/10.4161/mabs.19931; PMID: 22531442
   PubMed Web of Science ®Google Scholar
• http://www.immunologylink.com/FDA-APP-Abs.html. 2011.
   Google Scholar
• Woloschak GE, Krco CJ. Regulation of kappa/lambda immunoglobulin light chain expression in normal murine lymphocytes. Mol Immunol 1987; 24:751 - 7; http://dx.doi.org/10.1016/0161-5890(87)90058-7; PMID: 3116408
   PubMed Web of Science ®Google Scholar
• Burtrum D, Zhu Z, Lu D, Anderson DM, Prewett M, Pereira DS, et al. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo. Cancer Res 2003; 63:8912 - 21; PMID: 14695208
   PubMed Web of Science ®Google Scholar
• Stohl W, Hilbert DM. The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat Biotechnol 2012; 30:69 - 77; http://dx.doi.org/10.1038/nbt.2076; PMID: 22231104
   PubMed Web of Science ®Google Scholar
• Liu H, Chumsae C, Gaza-Bulseco G, Hurkmans K, Radziejewski CH. Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis. Anal Chem 2010; 82:5219 - 26; http://dx.doi.org/10.1021/ac100575n; PMID: 20491447
   PubMed Web of Science ®Google Scholar
• Montaño RF, Morrison SL. Influence of the isotype of the light chain on the properties of IgG. J Immunol 2002; 168:224 - 31; PMID: 11751966
   PubMed Web of Science ®Google Scholar
• Li XQ, Zhang T, Donnelly D. Selective loss of cysteine residues and disulphide bonds in a potato proteinase inhibitor II family. PLoS One 2011; 6:e18615; http://dx.doi.org/10.1371/journal.pone.0018615; PMID: 21494600
   PubMed Web of Science ®Google Scholar
• Grey HM. Presence of L-L interchain disulfide bonds in reconstituted gamma G molecules. J Immunol 1969; 102:848 - 51; PMID: 5768193
   PubMed Web of Science ®Google Scholar
• Labrijn AF, Buijsse AO, van den Bremer ET, Verwilligen AY, Bleeker WK, Thorpe SJ, et al. Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo. Nat Biotechnol 2009; 27:767 - 71; http://dx.doi.org/10.1038/nbt.1553; PMID: 19620983
   PubMed Web of Science ®Google Scholar
• Schuurman J, Perdok GJ, Gorter AD, Aalberse RC. The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds. Mol Immunol 2001; 38:1 - 8; http://dx.doi.org/10.1016/S0161-5890(01)00050-5; PMID: 11483205
   PubMed Web of Science ®Google Scholar
• Guo A, Han M, Martinez T, Ketchem RR, Novick S, Jochheim C, et al. Electrophoretic evidence for the presence of structural isoforms specific for the IgG2 isotype. Electrophoresis 2008; 29:2550 - 6; http://dx.doi.org/10.1002/elps.200800083; PMID: 18494039
   PubMed Web of Science ®Google Scholar
• Wypych J, Li M, Guo A, Zhang Z, Martinez T, Allen MJ, et al. Human IgG2 antibodies display disulfide-mediated structural isoforms. J Biol Chem 2008; 283:16194 - 205; http://dx.doi.org/10.1074/jbc.M709987200; PMID: 18339624
   PubMed Web of Science ®Google Scholar
• Martinez T, Guo A, Allen MJ, Han M, Pace D, Jones J, et al. Disulfide connectivity of human immunoglobulin G2 structural isoforms. Biochemistry 2008; 47:7496 - 508; http://dx.doi.org/10.1021/bi800576c; PMID: 18549248
   PubMed Web of Science ®Google Scholar
• Zhang B, Harder AG, Connelly HM, Maheu LL, Cockrill SL. Determination of Fab-hinge disulfide connectivity in structural isoforms of a recombinant human immunoglobulin G2 antibody. Anal Chem 2010; 82:1090 - 9; http://dx.doi.org/10.1021/ac902466z; PMID: 20039682
   PubMed Web of Science ®Google Scholar
• Brych SR, Gokarn YR, Hultgen H, Stevenson RJ, Rajan R, Matsumura M. Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation. J Pharm Sci 2010; 99:764 - 81; PMID: 19691118
   PubMed Web of Science ®Google Scholar
• Van Buren N, Rehder D, Gadgil H, Matsumura M, Jacob J. Elucidation of two major aggregation pathways in an IgG2 antibody. J Pharm Sci 2009; 98:3013 - 30; http://dx.doi.org/10.1002/jps.21514; PMID: 18680168
   PubMed Web of Science ®Google Scholar
• Natvig JB, Kunkel HG. Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes. Adv Immunol 1973; 16:1 - 59; http://dx.doi.org/10.1016/S0065-2776(08)60295-3; PMID: 4125921
   PubMedGoogle Scholar
• Liu H, Zhong S, Chumsae C, Radziejewski C, Hsieh CM. Effect of the light chain C-terminal serine residue on disulfide bond susceptibility of human immunoglobulin G1λ. Anal Biochem 2011; 408:277 - 83; http://dx.doi.org/10.1016/j.ab.2010.09.025; PMID: 20869344
   PubMed Web of Science ®Google Scholar
• Yan B, Boyd D, Kaschak T, Tsukuda J, Shen A, Lin Y, et al. Engineering upper hinge improves stability and effector function of a human IgG1. J Biol Chem 2012; 287:5891 - 7; http://dx.doi.org/10.1074/jbc.M111.311811; PMID: 22203673
   PubMed Web of Science ®Google Scholar
• Debler EW, Ito S, Seebeck FP, Heine A, Hilvert D, Wilson IA. Structural origins of efficient proton abstraction from carbon by a catalytic antibody. Proc Natl Acad Sci U S A 2005; 102:4984 - 9; http://dx.doi.org/10.1073/pnas.0409207102; PMID: 15788533
   PubMed Web of Science ®Google Scholar
• Lewis AP, Lemon SM, Barber KA, Murphy P, Parry NR, Peakman TC, et al. Rescue, expression, and analysis of a neutralizing human anti-hepatitis A virus monoclonal antibody. J Immunol 1993; 151:2829 - 38; PMID: 8395549
   PubMed Web of Science ®Google Scholar
• Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, et al. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J Biol Chem 2006; 281:15829 - 36; http://dx.doi.org/10.1074/jbc.M600697200; PMID: 16597622
   PubMed Web of Science ®Google Scholar
• Faber C, Shan L, Fan Z, Guddat LW, Furebring C, Ohlin M, et al. Three-dimensional structure of a human Fab with high affinity for tetanus toxoid. Immunotechnology 1998; 3:253 - 70; http://dx.doi.org/10.1016/S1380-2933(97)10003-3; PMID: 9530559
   PubMedGoogle Scholar
• Malia TJ, Obmolova G, Almagro JC, Gilliland GL, Teplyakov A. Crystal structure of human germline antibody 3-23/B3. Mol Immunol 2011; 48:1586 - 8; http://dx.doi.org/10.1016/j.molimm.2011.04.020; PMID: 21605907
   PubMed Web of Science ®Google Scholar
• Wong JW, Hogg PJ. Analysis of disulfide bonds in protein structures. J Thromb Haemost 2010; http://dx.doi.org/10.1111/j.1538-7836.2010.03894.x; PMID: 20456749
   PubMedGoogle Scholar
• Kuang Z, Yao S, Xu Y, Lewis RS, Low A, Masters SL, et al. SPRY domain-containing SOCS box protein 2: crystal structure and residues critical for protein binding. J Mol Biol 2009; 386:662 - 74; http://dx.doi.org/10.1016/j.jmb.2008.12.078; PMID: 19154741
   PubMed Web of Science ®Google Scholar
• Schmidt B, Hogg PJ. Search for allosteric disulfide bonds in NMR structures. BMC Struct Biol 2007; 7:49; http://dx.doi.org/10.1186/1472-6807-7-49; PMID: 17640393
   PubMed Web of Science ®Google Scholar
• Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 2010; 66:486 - 501; http://dx.doi.org/10.1107/S0907444910007493; PMID: 20383002
   PubMed Web of Science ®Google Scholar
• The PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC.
   Google Scholar
• Harris TK, Turner GJ. Structural basis of perturbed pKa values of catalytic groups in enzyme active sites. IUBMB Life 2002; 53:85 - 98; http://dx.doi.org/10.1080/15216540211468; PMID: 12049200
   PubMed Web of Science ®Google Scholar
• Kellner R, Mermet J-M, Otto M, Widmer HM, eds. Analytical Chemistry. Weinheim, NY: Wiley-VCH, 1998.
   Google Scholar
• Dall’Acqua WF, Cook KE, Damschroder MM, Woods RM, Wu H. Modulation of the effector functions of a human IgG1 through engineering of its hinge region. J Immunol 2006; 177:1129 - 38; PMID: 16818770
   PubMed Web of Science ®Google Scholar
• Dorai H, Wesolowski JS, Gillies SD. Role of inter-heavy and light chain disulfide bonds in the effector functions of human immunoglobulin IgG1. Mol Immunol 1992; 29:1487 - 91; http://dx.doi.org/10.1016/0161-5890(92)90222-J; PMID: 1454066
   PubMed Web of Science ®Google Scholar
• Orcutt KD, Ackerman ME, Cieslewicz M, Quiroz E, Slusarczyk AL, Frangioni JV, et al. A modular IgG-scFv bispecific antibody topology. Protein Eng Des Sel 2010; 23:221 - 8; http://dx.doi.org/10.1093/protein/gzp077; PMID: 20019028
   PubMed Web of Science ®Google Scholar
• Spangler JB, Manzari MT, Rosalia EK, Chen TF, Wittrup KD. Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repression. J Mol Biol 2012; 422:532 - 44; http://dx.doi.org/10.1016/j.jmb.2012.06.014; PMID: 22706026
   PubMed Web of Science ®Google Scholar
• Hendershot LM. Immunoglobulin heavy chain and binding protein complexes are dissociated in vivo by light chain addition. J Cell Biol 1990; 111:829 - 37; http://dx.doi.org/10.1083/jcb.111.3.829; PMID: 2118144
   PubMed Web of Science ®Google Scholar
• Reddy P, Sparvoli A, Fagioli C, Fassina G, Sitia R. Formation of reversible disulfide bonds with the protein matrix of the endoplasmic reticulum correlates with the retention of unassembled Ig light chains. EMBO J 1996; 15:2077 - 85; PMID: 8641273
   PubMed Web of Science ®Google Scholar
• Burmeister WP, Huber AH, Bjorkman PJ. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 1994; 372:379 - 83; http://dx.doi.org/10.1038/372379a0; PMID: 7969498
   PubMed Web of Science ®Google Scholar
• Dall’Acqua WF, Kiener PA, Wu H. Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J Biol Chem 2006; 281:23514 - 24; http://dx.doi.org/10.1074/jbc.M604292200; PMID: 16793771
   PubMed Web of Science ®Google Scholar
• Dall’Acqua WF, Woods RM, Ward ES, Palaszynski SR, Patel NK, Brewah YA, et al. Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences. J Immunol 2002; 169:5171 - 80; PMID: 12391234
   PubMed Web of Science ®Google Scholar
• Petkova SB, Akilesh S, Sproule TJ, Christianson GJ, Al Khabbaz H, Brown AC, et al. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol 2006; 18:1759 - 69; http://dx.doi.org/10.1093/intimm/dxl110; PMID: 17077181
   PubMed Web of Science ®Google Scholar
• Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403 - 10; PMID: 2231712
   PubMed Web of Science ®Google Scholar
• Bernstein FC, Koetzle TF, Williams GJ, Meyer EF Jr., Brice MD, Rodgers JR, et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. Arch Biochem Biophys 1978; 185:584 - 91; http://dx.doi.org/10.1016/0003-9861(78)90204-7; PMID: 626512
   PubMed Web of Science ®Google Scholar
• Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23:2947 - 8; http://dx.doi.org/10.1093/bioinformatics/btm404; PMID: 17846036
   PubMed Web of Science ®Google Scholar
• Holm L, Park J. DaliLite workbench for protein structure comparison. Bioinformatics 2000; 16:566 - 7; http://dx.doi.org/10.1093/bioinformatics/16.6.566; PMID: 10980157
   PubMed Web of Science ®Google Scholar